Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
높은 성장
회사의 매출은 지난 3년간 꾸준히 성장해왔으며, 연평균 15.55%의 증가율을 기록했습니다.
이익 전환
회사의 실적이 흑자로 전환되어, 최근 연간 순이익은 미화 달러에 달합니다.
과대 평가된
회사의 최신 PE은 170.71로, 최근 3년 기준 높은 백분위 범위에 속합니다.
기관 매수
최신 기관 보유 주식 수는 291.07M주이며, 전 분기 대비 3.94% 증가했습니다.
리언 쿠퍼맨가 보유
스타 투자자 리언 쿠퍼맨이(가) 이 주식 9.19M주를 보유하고 있습니다.